A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the two key pathological hallmarks of Alzheimer’s—tau protein and beta-amyloid—affect brain circuits in distinct yet synergistic ways, […]
In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples that can be obtained from a cheek swab or blood test, they can improve identification of people with COPD in the […]
Breast cancer is the world’s most prevalent cancer. Although earlier detection and targeted treatment have resulted in high survival rates, many breast cancer survivors experience fear of cancer recurrence. For some survivors this fear is […]
Testosterone worsens the damage caused by a heart attack by increasing the number of white blood cells released from the bone marrow. This is shown in a study by the University of Gothenburg, Sweden. The […]
Pregnancy-related deaths in the U.S. have risen 140% over the past three decades with heart disease a major cause, according to the American Heart Association. A new national survey commissioned by The Ohio State University […]
Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialed in South Australian hospitals actually has the potential to assist doctors and nurses to rapidly diagnose heart […]
The U.S. Food and Drug Administration has approved Axsome Therapeutics’ Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.This article was originally published on MedicalXpress.com
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential for other cancers as well.This article was originally published on […]
Heart disease is the leading cause of death in the U.S., according to the American Heart Association. Heart disease refers to a range of conditions, of which many can be prevented or treated by making […]
The U.S. Food and Drug Administration has approved Genentech’s Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca